content/01.introduction.md:4:BRAF
content/01.introduction.md:4:BRAF
content/01.introduction.md:4:BRAF
content/01.introduction.md:4:fide
content/01.introduction.md:4:MAPK
content/01.introduction.md:4:tumorigenesis
content/01.introduction.md:6:adenocarcinomas
content/01.introduction.md:6:BRAF
content/01.introduction.md:6:dedifferentiation
content/01.introduction.md:6:MAPK
content/01.introduction.md:6:MAPK
content/01.introduction.md:6:phenotypes
content/01.introduction.md:6:transcriptomic
content/01.introduction.md:6:tumorigenesis
content/01.introduction.md:8:adenocarcinomas
content/01.introduction.md:8:BRAF
content/01.introduction.md:8:MAPK
content/01.introduction.md:8:transcriptional
content/01.introduction.md:8:transcriptional
content/01.introduction.md:8:transcriptomes
content/01.introduction.md:10:BRAF
content/01.introduction.md:10:transcriptional
content/01.introduction.md:16:NSCLC
content/01.introduction.md:18:adenocarcinomas
content/01.introduction.md:18:alveoli
content/01.introduction.md:18:BRAF
content/01.introduction.md:18:EGFR
content/01.introduction.md:18:genomic
content/01.introduction.md:18:histological
content/01.introduction.md:18:histological
content/01.introduction.md:18:KRAS
content/01.introduction.md:18:MAPK
content/01.introduction.md:18:NSCLC
content/01.introduction.md:18:NSCLC
content/01.introduction.md:18:SCLC
content/01.introduction.md:18:subtype
content/01.introduction.md:22:ALK
content/01.introduction.md:22:autophagy
content/01.introduction.md:22:BRAF
content/01.introduction.md:22:Carboplatin
content/01.introduction.md:22:chemotherapeutics
content/01.introduction.md:22:Cisplatin
content/01.introduction.md:22:EGFR
content/01.introduction.md:22:immunotherapy
content/01.introduction.md:22:immunotherapy
content/01.introduction.md:22:MEK
content/01.introduction.md:22:Paclitaxel
content/01.introduction.md:22:Pemetrexed
content/01.introduction.md:22:ROS
content/01.introduction.md:22:TRK
content/01.introduction.md:24:ARAF
content/01.introduction.md:24:BRAF
content/01.introduction.md:24:BRAF
content/01.introduction.md:24:BRAF
content/01.introduction.md:24:constitutively
content/01.introduction.md:24:CRAF
content/01.introduction.md:24:EGF
content/01.introduction.md:24:EGF
content/01.introduction.md:24:glutamic
content/01.introduction.md:24:GTP
content/01.introduction.md:24:GTP
content/01.introduction.md:24:GTP
content/01.introduction.md:24:GTP
content/01.introduction.md:24:kinases
content/01.introduction.md:24:kinases
content/01.introduction.md:24:kinases
content/01.introduction.md:24:Kinases
content/01.introduction.md:24:ligand
content/01.introduction.md:24:ligand
content/01.introduction.md:24:ligands
content/01.introduction.md:24:MAPK
content/01.introduction.md:24:MAPK
content/01.introduction.md:24:MAPK
content/01.introduction.md:24:mitogens
content/01.introduction.md:24:NGF
content/01.introduction.md:24:oncogenic
content/01.introduction.md:24:oncogenic
content/01.introduction.md:24:phosphorylates
content/01.introduction.md:24:phosphorylates
content/01.introduction.md:24:RAS
content/01.introduction.md:24:RAS
content/01.introduction.md:24:RAS
content/01.introduction.md:24:RAS
content/01.introduction.md:24:RAS
content/01.introduction.md:24:RAS
content/01.introduction.md:24:RTKs
content/01.introduction.md:24:RTKs
content/01.introduction.md:24:transcriptional
content/01.introduction.md:24:Tyrosine
content/01.introduction.md:24:valine
content/01.introduction.md:26:autophagy
content/01.introduction.md:26:BRAF
content/01.introduction.md:26:BRAF
content/01.introduction.md:26:BRAF
content/01.introduction.md:26:Dabrafenib
content/01.introduction.md:26:kinases
content/01.introduction.md:26:MAPK
content/01.introduction.md:26:MEK
content/01.introduction.md:26:MEK
content/01.introduction.md:26:preclinical
content/01.introduction.md:26:Trametinib
content/01.introduction.md:29:proto
content/01.introduction.md:31:GEMMs
content/01.introduction.md:31:latencies
content/01.introduction.md:31:MNU
content/01.introduction.md:31:penetrance
content/01.introduction.md:33:Cre
content/01.introduction.md:33:Cre
content/01.introduction.md:33:doxycycline
content/01.introduction.md:33:inducible
content/01.introduction.md:33:KRAS
content/01.introduction.md:33:LoxP
content/01.introduction.md:33:LoxP
content/01.introduction.md:33:LoxP
content/01.introduction.md:33:polyadenylation
content/01.introduction.md:33:recombinase
content/01.introduction.md:33:transgenes
content/01.introduction.md:35:BRAF
content/01.introduction.md:35:preclinical
content/01.introduction.md:35:transcriptional
content/01.introduction.md:37:adenocarcinomas
content/01.introduction.md:37:BRAF
content/01.introduction.md:37:EGFR
content/01.introduction.md:37:GEMMs
content/01.introduction.md:37:KRAS
content/01.introduction.md:37:MAPK
content/01.introduction.md:39:BRAF
content/01.introduction.md:39:BRAF
content/01.introduction.md:39:BRAF
content/01.introduction.md:39:BRAF
content/01.introduction.md:39:CAAX
content/01.introduction.md:39:cDNA
content/01.introduction.md:39:Cre
content/01.introduction.md:39:Cre
content/01.introduction.md:39:fluorophore
content/01.introduction.md:39:LoxP
content/01.introduction.md:39:LoxP
content/01.introduction.md:39:oncoprotein
content/01.introduction.md:39:oncoprotein
content/01.introduction.md:39:TdTomato
content/01.introduction.md:41:adenomas
content/01.introduction.md:41:BRAF
content/01.introduction.md:41:BRAF
content/01.introduction.md:41:BRAF
content/01.introduction.md:41:BRAF
content/01.introduction.md:41:Hanahan
content/01.introduction.md:41:MAPK
content/01.introduction.md:41:oncogenic
content/01.introduction.md:41:pneumocytes
content/01.introduction.md:41:proto
content/01.introduction.md:41:Surfactant
content/01.introduction.md:41:Tumorigenesis
content/01.introduction.md:41:WNT
content/01.introduction.md:44:egfr
content/01.introduction.md:44:erk
content/01.introduction.md:44:mek
content/01.introduction.md:44:ras
content/01.introduction.md:46:luad
content/01.introduction.md:46:tumorigenesis
content/01.introduction.md:48:BRAF
content/01.introduction.md:48:gemms
content/01.introduction.md:52:wnt
content/01.introduction.md:58:antigene
content/01.introduction.md:58:decameric
content/01.introduction.md:58:oligomerization
content/01.introduction.md:58:tetramerization
content/01.introduction.md:58:transactivation
content/01.introduction.md:58:transactivation
content/01.introduction.md:58:transcriptional
content/01.introduction.md:58:transcriptional
content/01.introduction.md:58:transcriptional
content/01.introduction.md:60:Fraumeni
content/01.introduction.md:60:leukemias
content/01.introduction.md:64:phenotypes
content/01.introduction.md:64:stressor
content/01.introduction.md:66:cDNA
content/01.introduction.md:66:ectopic
content/01.introduction.md:66:misclassification
content/01.introduction.md:66:RAS
content/01.introduction.md:68:hemizygosity
content/01.introduction.md:68:hotspot
content/01.introduction.md:68:hotspots
content/01.introduction.md:68:tetramer
content/01.introduction.md:68:transcriptional
content/01.introduction.md:70:chemoresistance
content/01.introduction.md:70:Fraumeni
content/01.introduction.md:70:Fraumeni
content/01.introduction.md:70:GOF
content/01.introduction.md:70:GOF
content/01.introduction.md:70:LOF
content/01.introduction.md:70:LOF
content/01.introduction.md:70:missense
content/01.introduction.md:70:missense
content/01.introduction.md:70:tumorigenic
content/01.introduction.md:72:Catenin
content/01.introduction.md:72:CREB
content/01.introduction.md:72:GOF
content/01.introduction.md:72:KRAS
content/02.tubaseq.md:5:adenocarcinomas
content/02.tubaseq.md:5:adenocarcinomas
content/02.tubaseq.md:5:BRAF
content/02.tubaseq.md:5:BRAF
content/02.tubaseq.md:5:BRAF
content/02.tubaseq.md:5:CRISPR
content/02.tubaseq.md:5:EGFR
content/02.tubaseq.md:5:ERK
content/02.tubaseq.md:5:histone
content/02.tubaseq.md:5:lysine
content/02.tubaseq.md:5:MEK
content/02.tubaseq.md:5:methyltransferase
content/02.tubaseq.md:5:oncogenicity
content/02.tubaseq.md:5:pre
content/02.tubaseq.md:5:RAS
content/02.tubaseq.md:5:RNAs
content/02.tubaseq.md:5:syngenetic
content/02.tubaseq.md:5:tumorigenesis
content/02.tubaseq.md:10:dabrafenib
content/02.tubaseq.md:10:trametinib
content/02.tubaseq.md:11:BRAF
content/02.tubaseq.md:11:BRAF
content/02.tubaseq.md:11:differentially
content/02.tubaseq.md:12:BRAF
content/02.tubaseq.md:12:BRAF
content/02.tubaseq.md:12:BRAF
content/02.tubaseq.md:12:colorectal
content/02.tubaseq.md:13:GEMMs
content/02.tubaseq.md:13:pre
content/02.tubaseq.md:15:Genomic
content/02.tubaseq.md:16:histological
content/02.tubaseq.md:17:tumorigenesis
content/02.tubaseq.md:22:bona
content/02.tubaseq.md:22:fide
content/02.tubaseq.md:22:GEMMs
content/02.tubaseq.md:23:GEMMs
content/02.tubaseq.md:23:scalable
content/02.tubaseq.md:23:suboptimal
content/02.tubaseq.md:25:histological
content/02.tubaseq.md:25:IHC
content/02.tubaseq.md:25:immunohistochemistry
content/02.tubaseq.md:28:mor
content/02.tubaseq.md:28:rcode
content/02.tubaseq.md:28:uencing
content/02.tubaseq.md:28:Winslow
content/02.tubaseq.md:29:barcoded
content/02.tubaseq.md:29:Cre
content/02.tubaseq.md:29:Cre
content/02.tubaseq.md:29:lentiviral
content/02.tubaseq.md:29:recombinase
content/02.tubaseq.md:34:BRAF
content/02.tubaseq.md:34:tumorigenesis
content/02.tubaseq.md:35:adenoma
content/02.tubaseq.md:36:BRAF
content/02.tubaseq.md:36:stromal
content/02.tubaseq.md:37:BRAF
content/02.tubaseq.md:37:CRISPR
content/02.tubaseq.md:40:Adenoviral
content/02.tubaseq.md:40:GEMMs
content/02.tubaseq.md:40:lentiviral
content/02.tubaseq.md:40:numerosity
content/02.tubaseq.md:40:titrated
content/02.tubaseq.md:41:adenoviruses
content/02.tubaseq.md:41:barcode
content/02.tubaseq.md:41:lentiviral
content/02.tubaseq.md:42:CRISPR
content/02.tubaseq.md:42:lentiviruses
content/02.tubaseq.md:42:oncogenic
content/02.tubaseq.md:43:BRAF
content/02.tubaseq.md:43:LSL
content/02.tubaseq.md:44:barcoded
content/02.tubaseq.md:44:BRAF
content/02.tubaseq.md:44:BRAF
content/02.tubaseq.md:44:Cre
content/02.tubaseq.md:44:lentiviral
content/02.tubaseq.md:44:plasmids
content/02.tubaseq.md:44:recombinase
content/02.tubaseq.md:44:sgRNA
content/02.tubaseq.md:44:tumorigenesis
content/02.tubaseq.md:45:barcoded
content/02.tubaseq.md:45:lentiviral
content/02.tubaseq.md:45:lentiviruses
content/02.tubaseq.md:47:titer
content/02.tubaseq.md:47:titer
content/02.tubaseq.md:48:histologic
content/02.tubaseq.md:49:BRAF
content/02.tubaseq.md:50:barcode
content/02.tubaseq.md:50:genomic
content/02.tubaseq.md:51:barcoded
content/02.tubaseq.md:51:genomic
content/02.tubaseq.md:53:BRAF
content/02.tubaseq.md:54:BRAF
content/02.tubaseq.md:57:RNAs
content/02.tubaseq.md:57:statiscically
content/02.tubaseq.md:59:BRAF
content/02.tubaseq.md:60:BRAF
content/02.tubaseq.md:60:catenin
content/02.tubaseq.md:60:tumorigenesis
content/02.tubaseq.md:60:Wnt
content/02.tubaseq.md:61:catenin
content/02.tubaseq.md:62:BRAF
content/02.tubaseq.md:62:tumorigenesis
content/02.tubaseq.md:64:BRAF
content/02.tubaseq.md:64:RNAs
content/02.tubaseq.md:65:Addiionally
content/02.tubaseq.md:65:CRISPR
content/02.tubaseq.md:65:histological
content/02.tubaseq.md:65:reponse
content/02.tubaseq.md:66:immunohistochemistry
content/02.tubaseq.md:66:immunohistochemistry
content/02.tubaseq.md:67:BRAF
content/02.tubaseq.md:67:CRISPR
content/02.tubaseq.md:68:BRAF
content/02.tubaseq.md:70:adenocarcinomas
content/02.tubaseq.md:70:avaiable
content/02.tubaseq.md:70:BRAF
content/02.tubaseq.md:70:BRAF
content/02.tubaseq.md:70:genomic
content/02.tubaseq.md:77:MAPK
content/02.tubaseq.md:78:BRAF
content/02.tubaseq.md:78:Oncogenic
content/02.tubaseq.md:79:BRAF
content/02.tubaseq.md:79:tumorigenesis
content/02.tubaseq.md:80:BRAF
content/02.tubaseq.md:80:GEMMs
content/02.tubaseq.md:80:WNT
content/02.tubaseq.md:82:adenoma
content/02.tubaseq.md:82:BRAF
content/02.tubaseq.md:82:stromal
content/02.tubaseq.md:83:adenomas
content/02.tubaseq.md:83:BRAF
content/02.tubaseq.md:84:adenomas
content/02.tubaseq.md:84:BRAF
content/02.tubaseq.md:84:BRAF
content/02.tubaseq.md:84:doublings
content/02.tubaseq.md:84:doublings
content/02.tubaseq.md:84:histological
content/02.tubaseq.md:85:adenomas
content/02.tubaseq.md:85:BRAF
content/02.tubaseq.md:86:BRAF
content/02.tubaseq.md:87:BRAF
content/02.tubaseq.md:88:fibroblast
content/02.tubaseq.md:88:stromal
content/02.tubaseq.md:88:tumorigenic
content/02.tubaseq.md:89:adenomas
content/02.tubaseq.md:89:BRAF
content/02.tubaseq.md:92:BRAF
content/02.tubaseq.md:92:CRISPR
content/02.tubaseq.md:92:sgRNAs
content/02.tubaseq.md:93:bona
content/02.tubaseq.md:93:fide
content/02.tubaseq.md:94:Wnt
content/02.tubaseq.md:95:BRAF
content/02.tubaseq.md:95:WNT
content/02.tubaseq.md:96:WNT
content/02.tubaseq.md:97:BRAF
content/02.tubaseq.md:100:cBioPortal
content/02.tubaseq.md:101:histone
content/02.tubaseq.md:101:methyltransferase
content/02.tubaseq.md:101:trimethylation
content/02.tubaseq.md:103:mRNA
content/02.tubaseq.md:103:mRNA
content/02.tubaseq.md:103:TCGA
content/02.tubaseq.md:104:BRAF
content/02.tubaseq.md:105:MAPK
content/02.tubaseq.md:106:transcriptional
content/02.tubaseq.md:107:Felder's
content/02.tubaseq.md:107:KRAS
content/02.tubaseq.md:107:tumorigenesis
content/02.tubaseq.md:107:Winslow
content/02.tubaseq.md:108:BRAF
content/02.tubaseq.md:108:KRAS
content/02.tubaseq.md:110:BRAF
content/02.tubaseq.md:110:tumorigenesis
content/02.tubaseq.md:111:KRAS
content/02.tubaseq.md:111:sgRNAs
content/02.tubaseq.md:111:tumorigenic
content/02.tubaseq.md:114:transcriptional
content/02.tubaseq.md:116:CRISPR
content/02.tubaseq.md:116:tumorigenesis
content/02.tubaseq.md:118:adenocarcinomas
content/02.tubaseq.md:118:GEMMs
content/02.tubaseq.md:118:tumorigenesis
content/02.tubaseq.md:119:BRAF
content/02.tubaseq.md:119:tumorigenesis
content/02.tubaseq.md:120:adenocarcinomas
content/02.tubaseq.md:121:BRAF
content/02.tubaseq.md:122:BRAF
content/02.tubaseq.md:126:Biosafety
content/02.tubaseq.md:126:Biosafety
content/02.tubaseq.md:126:genotyping
content/02.tubaseq.md:126:intratracheal
content/02.tubaseq.md:126:intubation
content/02.tubaseq.md:126:Lentivirus
content/02.tubaseq.md:126:LSL
content/02.tubaseq.md:128:amlifying
content/02.tubaseq.md:128:AMPure
content/02.tubaseq.md:128:approximetley
content/02.tubaseq.md:128:barcode
content/02.tubaseq.md:128:Barcoded
content/02.tubaseq.md:128:Cre
content/02.tubaseq.md:128:CRISPR
content/02.tubaseq.md:128:DMEM
content/02.tubaseq.md:128:FBS
content/02.tubaseq.md:128:genomic
content/02.tubaseq.md:128:Genomic
content/02.tubaseq.md:128:HEK
content/02.tubaseq.md:128:intratracheal
content/02.tubaseq.md:128:intubation
content/02.tubaseq.md:128:lentiiral
content/02.tubaseq.md:128:lentiviral
content/02.tubaseq.md:128:lentiviral
content/02.tubaseq.md:128:Lentiviral
content/02.tubaseq.md:128:Lentivirus
content/02.tubaseq.md:128:LSL
content/02.tubaseq.md:128:ofmale
content/02.tubaseq.md:128:PCR
content/02.tubaseq.md:128:proteinase
content/02.tubaseq.md:128:Qubit
content/02.tubaseq.md:128:sgRNA
content/02.tubaseq.md:128:Suquencing
content/02.tubaseq.md:128:titered
content/02.tubaseq.md:128:Winslow
content/02.tubaseq.md:128:Winslow
content/02.tubaseq.md:131:eosin
content/02.tubaseq.md:131:HCI
content/02.tubaseq.md:131:hematoxylin
content/02.tubaseq.md:131:histech
content/02.tubaseq.md:131:Histech
content/02.tubaseq.md:131:Immunohistochemistry
content/02.tubaseq.md:131:mAb
content/02.tubaseq.md:131:perfused
content/02.tubaseq.md:131:QuantCenter
content/02.tubaseq.md:131:quantifie
content/02.tubaseq.md:133:cBio
content/02.tubaseq.md:133:KMplotter
content/02.tubaseq.md:133:ocurring
content/02.tubaseq.md:133:TNMplot
content/02.tubaseq.md:133:vesus
content/02.tubaseq.md:135:Cre
content/02.tubaseq.md:135:Lenti
content/02.tubaseq.md:135:LSL
content/02.tubaseq.md:135:LSL
content/02.tubaseq.md:135:LSL
content/02.tubaseq.md:135:LSL
content/02.tubaseq.md:135:plasmid
content/02.tubaseq.md:135:sgRNA
content/02.tubaseq.md:135:supressors
content/02.tubaseq.md:137:Jitter
content/02.tubaseq.md:137:LSL
content/02.tubaseq.md:137:LSL
content/02.tubaseq.md:139:identifed
content/02.tubaseq.md:139:Jitter
content/02.tubaseq.md:139:LSL
content/02.tubaseq.md:139:LSL
content/02.tubaseq.md:139:seperated
content/02.tubaseq.md:139:sgID
content/02.tubaseq.md:141:BRAF
content/02.tubaseq.md:141:Cre
content/02.tubaseq.md:141:Cre
content/02.tubaseq.md:141:Lenti
content/02.tubaseq.md:141:Lenti
content/02.tubaseq.md:141:LSL
content/02.tubaseq.md:141:PFU
content/02.tubaseq.md:143:positivty
content/02.tubaseq.md:143:QuantCenter
content/02.tubaseq.md:143:simuletaneously
content/02.tubaseq.md:145:BRAF
content/02.tubaseq.md:145:dataset
content/02.tubaseq.md:145:KMplotter
content/02.tubaseq.md:145:mRNA
content/02.tubaseq.md:145:mRNA
content/02.tubaseq.md:145:TGCA
content/03.p53.md:4:adenocarcinomas
content/03.p53.md:4:ARF
content/03.p53.md:4:BRAF
content/03.p53.md:4:BRAF
content/03.p53.md:4:BRAF
content/03.p53.md:4:dedifferentiation
content/03.p53.md:4:GEMMs
content/03.p53.md:4:GEMMs
content/03.p53.md:4:homologs
content/03.p53.md:4:hotspot
content/03.p53.md:4:hotspot
content/03.p53.md:4:MEK
content/03.p53.md:4:missense
content/03.p53.md:4:transcriptome
content/03.p53.md:4:vitro
content/03.p53.md:4:vivo
content/03.p53.md:8:BRAF
content/03.p53.md:8:BRAF
content/03.p53.md:8:BRAF
content/03.p53.md:8:EGFR
content/03.p53.md:8:EGFR
content/03.p53.md:8:EGFR
content/03.p53.md:8:GEMMs
content/03.p53.md:8:histologically
content/03.p53.md:8:KRAS
content/03.p53.md:8:KRAS
content/03.p53.md:8:KRAS
content/03.p53.md:8:LUAD
content/03.p53.md:8:LUAD
content/03.p53.md:8:LUAD
content/03.p53.md:8:MAPK
content/03.p53.md:8:MAPK
content/03.p53.md:8:mutationally
content/03.p53.md:8:oncoproteins
content/03.p53.md:8:pneumocyte
content/03.p53.md:8:Siegel
content/03.p53.md:8:transformative
content/03.p53.md:10:ARF
content/03.p53.md:10:chemoresistance
content/03.p53.md:10:genomic
content/03.p53.md:10:LUAD
content/03.p53.md:10:MDMX
content/03.p53.md:10:phenotypes
content/03.p53.md:10:proliferative
content/03.p53.md:10:TGF
content/03.p53.md:10:transcriptional
content/03.p53.md:10:transcriptional
content/03.p53.md:10:transcriptional
content/03.p53.md:12:BRAF
content/03.p53.md:12:BRAF
content/03.p53.md:12:dysregulation
content/03.p53.md:12:GEMMs
content/03.p53.md:12:homologs
content/03.p53.md:12:hotspots
content/03.p53.md:12:phenotypic
content/03.p53.md:12:tumorigenesis
content/03.p53.md:14:BRAF
content/03.p53.md:14:BRAF
content/03.p53.md:14:hotspot
content/03.p53.md:14:tumorigenesis
content/03.p53.md:14:tumorigenesis
content/03.p53.md:18:BRAF
content/03.p53.md:18:Differentially
content/03.p53.md:18:Tumorigenesis
content/03.p53.md:20:adenovirus
content/03.p53.md:20:BRAF
content/03.p53.md:20:BRAF
content/03.p53.md:20:Cre
content/03.p53.md:20:Cre
content/03.p53.md:20:Cre
content/03.p53.md:20:pfu
content/03.p53.md:20:pneumocytes
content/03.p53.md:20:recombinase
content/03.p53.md:20:Spc
content/03.p53.md:20:surfactant
content/03.p53.md:20:tumorigenic
content/03.p53.md:22:heterozygosity
content/03.p53.md:22:heterozygous
content/03.p53.md:22:LOH
content/03.p53.md:24:homozygous
content/03.p53.md:27:Dedifferentiation
content/03.p53.md:28:dedifferentiated
content/03.p53.md:28:dedifferentiation
content/03.p53.md:28:dedifferentiation
content/03.p53.md:28:dedifferentiation
content/03.p53.md:28:flfl
content/03.p53.md:28:IHC
content/03.p53.md:28:LUAD
content/03.p53.md:28:LUADs
content/03.p53.md:28:SPC
content/03.p53.md:28:SPC
content/03.p53.md:28:transcriptional
content/03.p53.md:30:atypia
content/03.p53.md:30:heterozygous
content/03.p53.md:30:homozygous
content/03.p53.md:30:homozygous
content/03.p53.md:30:Immunohistochemistry
content/03.p53.md:30:immunostaining
content/03.p53.md:30:phosphorylated
content/03.p53.md:30:transcriptional
content/03.p53.md:31:ARF
content/03.p53.md:31:ARF
content/03.p53.md:31:ARF
content/03.p53.md:31:BRAF
content/03.p53.md:31:homozygous
content/03.p53.md:31:homozygous
content/03.p53.md:31:immunofluorescence
content/03.p53.md:33:BRAF
content/03.p53.md:33:MEK
content/03.p53.md:34:BRAF
content/03.p53.md:34:chemotherapies
content/03.p53.md:34:Interstingly
content/03.p53.md:34:MAPK
content/03.p53.md:36:Cre
content/03.p53.md:36:dabrafenib
content/03.p53.md:36:dabrafenib
content/03.p53.md:36:flfl
content/03.p53.md:36:inhibtion
content/03.p53.md:36:MAPK
content/03.p53.md:36:MAPK
content/03.p53.md:36:MAPK
content/03.p53.md:36:phosphorylated
content/03.p53.md:36:proliferative
content/03.p53.md:36:Spc
content/03.p53.md:36:trametinib
content/03.p53.md:38:doxycycline
content/03.p53.md:38:GFP
content/03.p53.md:38:MAPK
content/03.p53.md:38:phenotypes
content/03.p53.md:38:plasmid
content/03.p53.md:38:sucessful
content/03.p53.md:40:BRAF
content/03.p53.md:40:BRAF
content/03.p53.md:40:homolog
content/03.p53.md:40:hotspot
content/03.p53.md:40:lentivirus
content/03.p53.md:40:MEK
content/03.p53.md:40:missense
content/03.p53.md:40:proliferative
content/03.p53.md:43:BRAF
content/03.p53.md:43:transcriptome
content/03.p53.md:44:dedifferentiation
content/03.p53.md:44:MYC
content/03.p53.md:44:phenotypes
content/03.p53.md:44:transcriptional
content/03.p53.md:44:transcriptional
content/03.p53.md:44:transcriptional
content/03.p53.md:44:transcriptomic
content/03.p53.md:44:upregulated
content/03.p53.md:46:PDGFR
content/03.p53.md:47:differentially
content/03.p53.md:47:Imatinib
content/03.p53.md:47:ligand
content/03.p53.md:47:MAPK
content/03.p53.md:47:MAPK
content/03.p53.md:47:PDFRB
content/03.p53.md:47:PDGF
content/03.p53.md:47:PDGFR
content/03.p53.md:47:PDGFR
content/03.p53.md:47:PDGFR
content/03.p53.md:47:PDGFR
content/03.p53.md:47:PDGFR
content/03.p53.md:47:PDGFR
content/03.p53.md:47:PDGFR
content/03.p53.md:47:PDGFRB
content/03.p53.md:47:PDGFRB
content/03.p53.md:47:PDGFRB
content/03.p53.md:47:Phospohorylated
content/03.p53.md:47:recepter
content/03.p53.md:47:recombinant
content/03.p53.md:47:upregulated
content/03.p53.md:47:upregulation
content/03.p53.md:52:adenocarcinomas
content/03.p53.md:52:BRAF
content/03.p53.md:52:Cre
content/03.p53.md:52:Cre
content/03.p53.md:52:dedifferentiation
content/03.p53.md:52:hotspot
content/03.p53.md:52:leukemias
content/03.p53.md:52:missense
content/03.p53.md:52:missense
content/03.p53.md:54:BRAF
content/03.p53.md:54:BRAF
content/03.p53.md:54:dabrafenib
content/03.p53.md:54:heterozygosity
content/03.p53.md:54:missense
content/03.p53.md:54:trametinib
content/03.p53.md:54:tumorigenesis
content/03.p53.md:56:adenocarcinomas
content/03.p53.md:56:ARF
content/03.p53.md:56:ARF
content/03.p53.md:56:ARF
content/03.p53.md:56:ARF
content/03.p53.md:56:ARF
content/03.p53.md:56:ARF
content/03.p53.md:56:BRAF
content/03.p53.md:56:BRAF
content/03.p53.md:56:GOF
content/03.p53.md:56:Hyperactivation
content/03.p53.md:56:MAPK
content/03.p53.md:56:MAPK
content/03.p53.md:56:oncogenic
content/03.p53.md:56:PDAC
content/03.p53.md:56:phosphorylated
content/03.p53.md:58:GOF
content/03.p53.md:58:oligomerization
content/03.p53.md:58:transactivation
content/03.p53.md:58:transcriptional
content/03.p53.md:58:transcriptomes
content/03.p53.md:60:BRAF
content/03.p53.md:60:BRAF
content/03.p53.md:60:BRAF
content/03.p53.md:60:chemotherapies
content/03.p53.md:60:GOF
content/03.p53.md:60:Imatinib
content/03.p53.md:60:immunoblotting
content/03.p53.md:60:ligands
content/03.p53.md:60:LSL
content/03.p53.md:60:MEK
content/03.p53.md:60:PDGF
content/03.p53.md:60:PDGFR
content/03.p53.md:60:PDGFR
content/03.p53.md:60:phenotypes
content/03.p53.md:60:transcriptional
content/03.p53.md:62:dabrafenib
content/03.p53.md:62:dedifferentiation
content/03.p53.md:62:pre
content/03.p53.md:62:proliferative
content/03.p53.md:62:trametinib
content/03.p53.md:62:transcriptomes
content/03.p53.md:62:tumorigenic
content/03.p53.md:66:Adeno
content/03.p53.md:66:Biosafety
content/03.p53.md:66:Biosafety
content/03.p53.md:66:BRAF
content/03.p53.md:66:CRE
content/03.p53.md:66:genotyping
content/03.p53.md:66:genotyping
content/03.p53.md:66:Gigi
content/03.p53.md:66:Lozano
content/03.p53.md:66:SPC
content/03.p53.md:68:BRAF
content/03.p53.md:68:Collagenase
content/03.p53.md:68:cytometry
content/03.p53.md:68:dispase
content/03.p53.md:68:DMEM
content/03.p53.md:68:elastase
content/03.p53.md:68:lysis
content/03.p53.md:68:passaged
content/03.p53.md:68:resuspended
content/03.p53.md:68:resuspended
content/03.p53.md:68:RPMI
content/03.p53.md:68:stromal
content/03.p53.md:68:tdTomato
content/03.p53.md:68:trypsinization
content/03.p53.md:70:DMEM
content/03.p53.md:70:FBS
content/03.p53.md:70:HCC
content/03.p53.md:70:mycoplasma
content/03.p53.md:72:Caseviewer
content/03.p53.md:72:eosin
content/03.p53.md:72:Hematoxylin
content/03.p53.md:72:Histech
content/03.p53.md:72:Histech
content/03.p53.md:72:Histech
content/03.p53.md:72:IHC
content/03.p53.md:72:Pannoramic
content/03.p53.md:72:QuantCenter
content/03.p53.md:72:QuantCenter
content/03.p53.md:72:Thermo
content/03.p53.md:75:BCA
content/03.p53.md:75:clX
content/03.p53.md:75:Immunoblotting
content/03.p53.md:75:Licor
content/03.p53.md:75:lysate
content/03.p53.md:75:lysed
content/03.p53.md:75:microgram
content/03.p53.md:75:phosphatase
content/03.p53.md:75:protease
content/03.p53.md:75:PVDF
content/03.p53.md:75:RIPA
content/03.p53.md:75:SDS
content/03.p53.md:75:supernatant
content/03.p53.md:75:tris
content/03.p53.md:77:fastq
content/03.p53.md:77:FastQC
content/03.p53.md:77:FeatureCounts
content/03.p53.md:77:Galazy
content/03.p53.md:77:Illumina
content/03.p53.md:77:mRNA
content/03.p53.md:77:MultiQC
content/03.p53.md:77:Qiagen
content/03.p53.md:77:TruSeq
content/03.p53.md:77:UDI
content/03.p53.md:79:BRAF
content/03.p53.md:79:Cre
content/03.p53.md:79:Cre
content/03.p53.md:79:Priot
content/03.p53.md:79:TdTomato
content/03.p53.md:81:BRAF
content/03.p53.md:81:Cre
content/03.p53.md:81:Cre
content/03.p53.md:81:Cre
content/03.p53.md:81:differentially
content/03.p53.md:81:histological
content/03.p53.md:81:recombinase
content/03.p53.md:81:Recombinase
content/03.p53.md:81:Recombinase
content/03.p53.md:81:tumorigenesis
content/03.p53.md:85:differentially
content/03.p53.md:85:heterozygous
content/03.p53.md:85:homozygous
content/03.p53.md:85:Kaplan
content/03.p53.md:85:Kaplan
content/03.p53.md:87:IHC
content/03.p53.md:87:immunostaing
content/03.p53.md:87:Missense
content/03.p53.md:87:SPC
content/03.p53.md:89:ARF
content/03.p53.md:89:ARF
content/03.p53.md:89:atypia
content/03.p53.md:89:immunostaining
content/03.p53.md:89:immunostaining
content/03.p53.md:89:phospho
content/03.p53.md:89:SPC
content/03.p53.md:91:dabrafenib
content/03.p53.md:91:dabrafenib
content/03.p53.md:91:GEMMs
content/03.p53.md:91:MAPK
content/03.p53.md:91:MAPKi
content/03.p53.md:91:trametinib
content/03.p53.md:94:CytoTox
content/03.p53.md:94:dabrafinib
content/03.p53.md:94:dabrafinib
content/03.p53.md:94:Incucyte
content/03.p53.md:94:MAPKi
content/03.p53.md:94:trametinib
content/03.p53.md:94:trametinib
content/03.p53.md:96:doxycycline
content/03.p53.md:96:Doxycycline
content/03.p53.md:98:dabrafenib
content/03.p53.md:98:ectopic
content/03.p53.md:98:HCC
content/03.p53.md:98:Incucyte
content/03.p53.md:98:MAPKi
content/03.p53.md:98:trametenib
content/03.p53.md:101:Differentially
content/03.p53.md:101:transcriptome
content/03.p53.md:103:differentially
content/03.p53.md:103:differentially
content/03.p53.md:103:differntially
content/03.p53.md:105:GEMM
content/03.p53.md:105:IHC
content/03.p53.md:105:PDGF
content/03.p53.md:105:PDGFRB
content/03.p53.md:105:PDGFRB
content/03.p53.md:105:upregulated
content/03.p53.md:107:Imatinib
content/03.p53.md:107:patway
content/03.p53.md:107:PDGF
content/03.p53.md:107:PDGF
content/03.p53.md:107:PDGF
content/04.singlecell.md:4:adenocarcinomas
content/04.singlecell.md:4:adenocarcinomas
content/04.singlecell.md:4:BRAF
content/04.singlecell.md:4:BRAF
content/04.singlecell.md:4:genomic
content/04.singlecell.md:4:genotypes
content/04.singlecell.md:4:histological
content/04.singlecell.md:4:oncoprotein
content/04.singlecell.md:4:stereotypically
content/04.singlecell.md:4:transcriptomes
content/04.singlecell.md:7:alveoli
content/04.singlecell.md:7:alveoli
content/04.singlecell.md:7:alveoli
content/04.singlecell.md:7:cuboidal
content/04.singlecell.md:7:meshwork
content/04.singlecell.md:7:stereotypic
content/04.singlecell.md:7:surfactant
content/04.singlecell.md:9:adenocarcinomas
content/04.singlecell.md:9:alveoli
content/04.singlecell.md:11:GEMM
content/04.singlecell.md:11:GEMMs
content/04.singlecell.md:11:intra
content/04.singlecell.md:11:pre
content/04.singlecell.md:11:scRNA
content/04.singlecell.md:11:transcriptional
content/04.singlecell.md:11:transcriptomes
content/04.singlecell.md:11:tumoral
content/04.singlecell.md:13:adenocarcinomas
content/04.singlecell.md:13:adenocarcinomas
content/04.singlecell.md:13:adenocarcinomas
content/04.singlecell.md:13:adenocarcinomas
content/04.singlecell.md:13:BRAF
content/04.singlecell.md:13:GEMMs
content/04.singlecell.md:13:GEMMs
content/04.singlecell.md:13:GEMMs
content/04.singlecell.md:13:genotype
content/04.singlecell.md:13:transcriptomes
content/04.singlecell.md:13:tumorigenesis
content/04.singlecell.md:18:adenoviral
content/04.singlecell.md:18:BRAF
content/04.singlecell.md:18:BRAF
content/04.singlecell.md:18:BRAF
content/04.singlecell.md:18:Cre
content/04.singlecell.md:18:dabrafenib
content/04.singlecell.md:18:dabrafenib
content/04.singlecell.md:18:FACS
content/04.singlecell.md:18:fluorescently
content/04.singlecell.md:18:genotype
content/04.singlecell.md:18:Seuratbased
content/04.singlecell.md:18:Spc
content/04.singlecell.md:18:trametinib
content/04.singlecell.md:18:trametinib
content/04.singlecell.md:18:transcriptome
content/04.singlecell.md:20:bipotent
content/04.singlecell.md:20:BRAF
content/04.singlecell.md:20:dataset
content/04.singlecell.md:20:KRAS
content/04.singlecell.md:20:mesenchymal
content/04.singlecell.md:20:positivity
content/04.singlecell.md:20:Reclustering
content/04.singlecell.md:20:stromal
content/04.singlecell.md:20:TdTomato
content/04.singlecell.md:20:transcriptional
content/04.singlecell.md:20:tumorigenesis
content/04.singlecell.md:22:dabrafenib
content/04.singlecell.md:22:genotypes
content/04.singlecell.md:22:MAPK
content/04.singlecell.md:22:MAPK
content/04.singlecell.md:22:MAPK
content/04.singlecell.md:22:MAPKi
content/04.singlecell.md:22:trametinib
content/04.singlecell.md:22:transcriptional
content/04.singlecell.md:22:transcriptional
content/04.singlecell.md:24:downregulation
content/04.singlecell.md:24:scRNA
content/04.singlecell.md:24:transcriptional
content/04.singlecell.md:26:differentially
content/04.singlecell.md:26:genomic
content/04.singlecell.md:26:genotype
content/04.singlecell.md:26:genotype
content/04.singlecell.md:26:genotype
content/04.singlecell.md:26:genotypes
content/04.singlecell.md:30:adenocarcinomas
content/04.singlecell.md:30:BRAF
content/04.singlecell.md:30:BRAF
content/04.singlecell.md:30:MAPK
content/04.singlecell.md:30:MAPK
content/04.singlecell.md:30:mimick
content/04.singlecell.md:30:oncogenic
content/04.singlecell.md:30:scRNA
content/04.singlecell.md:30:transcriptional
content/04.singlecell.md:32:dedifferentiation
content/04.singlecell.md:32:genomic
content/04.singlecell.md:32:genomic
content/04.singlecell.md:32:genotypes
content/04.singlecell.md:32:KRAS
content/04.singlecell.md:32:pre
content/04.singlecell.md:32:transcriptional
content/04.singlecell.md:32:tumorigenesis
content/04.singlecell.md:34:genomic
content/04.singlecell.md:34:genotype
content/04.singlecell.md:34:genotypes
content/04.singlecell.md:34:missense
content/04.singlecell.md:34:scRNA
content/04.singlecell.md:34:transcriptional
content/04.singlecell.md:34:transcriptomic
content/04.singlecell.md:35:genotype
content/04.singlecell.md:35:scRNA
content/04.singlecell.md:35:transcriptional
content/04.singlecell.md:37:genotypes
content/04.singlecell.md:37:homogenous
content/04.singlecell.md:37:MAPK
content/04.singlecell.md:37:MAPK
content/04.singlecell.md:37:MAPK
content/04.singlecell.md:37:MAPK
content/04.singlecell.md:37:MAPK
content/04.singlecell.md:37:transcriptional
content/04.singlecell.md:37:transcriptional
content/04.singlecell.md:37:transcriptional
content/04.singlecell.md:39:BRAF
content/04.singlecell.md:39:BRAF
content/04.singlecell.md:39:genotypes
content/04.singlecell.md:39:genotypes
content/04.singlecell.md:39:stereotypic
content/04.singlecell.md:39:transcriptional
content/04.singlecell.md:39:transcriptional
content/04.singlecell.md:39:transcriptomes
content/04.singlecell.md:42:Adeno
content/04.singlecell.md:42:Biosafety
content/04.singlecell.md:42:Biosafety
content/04.singlecell.md:42:CRE
content/04.singlecell.md:42:genotyping
content/04.singlecell.md:42:genotyping
content/04.singlecell.md:42:Gigi
content/04.singlecell.md:42:Lozano
content/04.singlecell.md:42:SPC
content/04.singlecell.md:44:BD
content/04.singlecell.md:44:Cre
content/04.singlecell.md:44:cytometer
content/04.singlecell.md:44:dabrafenib
content/04.singlecell.md:44:HCI
content/04.singlecell.md:44:previusly
content/04.singlecell.md:44:Spc
content/04.singlecell.md:44:trametenib
content/04.singlecell.md:46:BCA
content/04.singlecell.md:46:clX
content/04.singlecell.md:46:Immunoblotting
content/04.singlecell.md:46:Licor
content/04.singlecell.md:46:lysate
content/04.singlecell.md:46:lysed
content/04.singlecell.md:46:microgram
content/04.singlecell.md:46:phosphatase
content/04.singlecell.md:46:protease
content/04.singlecell.md:46:PVDF
content/04.singlecell.md:46:RIPA
content/04.singlecell.md:46:SDS
content/04.singlecell.md:46:supernatant
content/04.singlecell.md:46:tris
content/04.singlecell.md:48:fastq
content/04.singlecell.md:48:FastQC
content/04.singlecell.md:48:FeatureCounts
content/04.singlecell.md:48:Galazy
content/04.singlecell.md:48:Illumina
content/04.singlecell.md:48:mRNA
content/04.singlecell.md:48:MultiQC
content/04.singlecell.md:48:Qiagen
content/04.singlecell.md:48:TruSeq
content/04.singlecell.md:48:UDI
content/04.singlecell.md:50:ARF
content/04.singlecell.md:50:Immunofluoresence
content/04.singlecell.md:50:Immunohistochemistry
content/04.singlecell.md:50:Immunohistochemistry
content/04.singlecell.md:50:phospho
content/04.singlecell.md:50:SPC
content/04.singlecell.md:54:genotypes
content/04.singlecell.md:56:mesenchymal
content/04.singlecell.md:58:BRAF
content/04.singlecell.md:58:transcripional
content/04.singlecell.md:58:tumorigenesis
content/04.singlecell.md:61:differentially
content/04.singlecell.md:61:Heatmap
content/04.singlecell.md:61:Transcriptional
content/04.singlecell.md:61:UMAP
content/04.singlecell.md:63:BRAV
content/04.singlecell.md:63:differentially
content/04.singlecell.md:63:Heatmap
content/04.singlecell.md:63:identifed
content/04.singlecell.md:63:MAPK
content/04.singlecell.md:63:MAPK
content/04.singlecell.md:63:sigure
content/04.singlecell.md:63:transcriptional
content/04.singlecell.md:66:BRAV
content/04.singlecell.md:66:differentially
content/04.singlecell.md:66:Heatmap
content/04.singlecell.md:66:transcriptional
content/04.singlecell.md:66:upregulated
content/04.singlecell.md:66:wildtype
content/04.singlecell.md:66:wildtype
content/04.singlecell.md:68:Genotpye
content/04.singlecell.md:68:Heatmap
content/06.future.md:4:BRAF
content/06.future.md:4:BRAF
content/06.future.md:4:scRNA
content/06.future.md:4:tumorigenesis
content/06.future.md:6:MAPK
content/06.future.md:6:MAPK
content/06.future.md:6:preclinical
content/06.future.md:8:BRAF
content/06.future.md:8:dedifferentiation
content/06.future.md:8:hyperactivation
content/06.future.md:8:KRAS
content/06.future.md:8:KRAS
content/06.future.md:8:KRAS
content/06.future.md:8:MAPK
content/06.future.md:8:MAPK
content/06.future.md:8:MAPK
content/06.future.md:8:MAPK
content/06.future.md:8:MAPK
content/06.future.md:8:MAPK
content/06.future.md:8:mutationally
content/06.future.md:8:tumorigenesis
content/06.future.md:8:tumorigenesis
content/06.future.md:8:tumorigenesis
content/06.future.md:10:ARF
content/06.future.md:10:MAPK
content/06.future.md:10:MAPK
content/06.future.md:10:MAPK
content/06.future.md:10:oncogenic
content/06.future.md:10:supression
content/06.future.md:10:tumorigenesis
content/06.future.md:10:WNT
content/06.future.md:10:WNT
content/06.future.md:12:aneuploidy
content/06.future.md:12:BRAF
content/06.future.md:12:BRAF
content/06.future.md:12:differentially
content/06.future.md:12:genomic
content/06.future.md:12:hotspot
content/06.future.md:12:isogenic
content/06.future.md:12:MAPK
content/06.future.md:12:missense
content/06.future.md:12:missense
content/06.future.md:12:phenotypic
content/06.future.md:12:transcriptional
content/06.future.md:12:tumorigenesis
content/06.future.md:14:colorectal
content/06.future.md:14:CRISPR
content/06.future.md:16:ARF
content/06.future.md:16:ARF
content/06.future.md:16:ARF
content/06.future.md:16:ARF
content/06.future.md:16:ARF
content/06.future.md:16:ARF
content/06.future.md:16:ARF
content/06.future.md:16:ARF
content/06.future.md:16:BRAF
content/06.future.md:16:BRAF
content/06.future.md:16:MAPK
content/06.future.md:16:RNAs
content/06.future.md:16:siRNAs
content/06.future.md:16:tumorigenesis
content/06.future.md:20:MAPK
content/06.future.md:20:MAPK
content/06.future.md:20:occured
content/06.future.md:21:MAPK
content/06.future.md:21:MAPK
content/06.future.md:21:MAPK
content/06.future.md:21:MAPK
content/06.future.md:21:MAPK
content/06.future.md:23:contraindicator
content/06.future.md:23:genomic
content/06.future.md:23:MAPK
content/06.future.md:23:preclinical
content/06.future.md:25:autophagy
content/06.future.md:25:BRAFi
content/06.future.md:25:dabrafenib
content/06.future.md:25:ERKi
content/06.future.md:25:MAPK
content/06.future.md:25:MAPK
content/06.future.md:25:MAPK
content/06.future.md:25:MEKi
content/06.future.md:25:trametinib
content/06.future.md:27:BRAF
content/06.future.md:27:dysregulation
content/06.future.md:27:transcriptional
content/06.future.md:27:transcriptomes
content/06.future.md:27:tumorigenesis
content/06.future.md:27:undescribed
content/06.future.md:29:BRAF
content/06.future.md:29:BRAF
content/06.future.md:29:genomic
content/06.future.md:29:MAPK
content/06.future.md:29:preclinical
content/06.future.md:29:tumorigenesis
content/06.future.md:29:tumorigenesis
content/07.Methods.md:2:Adeno
content/07.Methods.md:2:Biosafety
content/07.Methods.md:2:Biosafety
content/07.Methods.md:2:BRAF
content/07.Methods.md:2:CRE
content/07.Methods.md:2:genotyping
content/07.Methods.md:2:genotyping
content/07.Methods.md:2:Gigi
content/07.Methods.md:2:Lozano
content/07.Methods.md:2:SPC
content/07.Methods.md:4:amlifying
content/07.Methods.md:4:AMPure
content/07.Methods.md:4:approximetley
content/07.Methods.md:4:barcode
content/07.Methods.md:4:Barcoded
content/07.Methods.md:4:Cre
content/07.Methods.md:4:CRISPR
content/07.Methods.md:4:DMEM
content/07.Methods.md:4:FBS
content/07.Methods.md:4:genomic
content/07.Methods.md:4:Genomic
content/07.Methods.md:4:HEK
content/07.Methods.md:4:intratracheal
content/07.Methods.md:4:intubation
content/07.Methods.md:4:lentiiral
content/07.Methods.md:4:lentiviral
content/07.Methods.md:4:lentiviral
content/07.Methods.md:4:Lentiviral
content/07.Methods.md:4:Lentivirus
content/07.Methods.md:4:LSL
content/07.Methods.md:4:ofmale
content/07.Methods.md:4:PCR
content/07.Methods.md:4:proteinase
content/07.Methods.md:4:Qubit
content/07.Methods.md:4:sgRNA
content/07.Methods.md:4:Suquencing
content/07.Methods.md:4:titered
content/07.Methods.md:4:Winslow
content/07.Methods.md:4:Winslow
content/07.Methods.md:6:BRAF
content/07.Methods.md:6:Collagenase
content/07.Methods.md:6:cytometry
content/07.Methods.md:6:dispase
content/07.Methods.md:6:DMEM
content/07.Methods.md:6:elastase
content/07.Methods.md:6:lysis
content/07.Methods.md:6:passaged
content/07.Methods.md:6:resuspended
content/07.Methods.md:6:resuspended
content/07.Methods.md:6:RPMI
content/07.Methods.md:6:stromal
content/07.Methods.md:6:tdTomato
content/07.Methods.md:6:trypsinization
content/07.Methods.md:8:DMEM
content/07.Methods.md:8:FBS
content/07.Methods.md:8:HCC
content/07.Methods.md:8:mycoplasma
content/07.Methods.md:10:BCA
content/07.Methods.md:10:clX
content/07.Methods.md:10:Immunoblotting
content/07.Methods.md:10:Licor
content/07.Methods.md:10:lysate
content/07.Methods.md:10:lysed
content/07.Methods.md:10:microgram
content/07.Methods.md:10:phosphatase
content/07.Methods.md:10:protease
content/07.Methods.md:10:PVDF
content/07.Methods.md:10:RIPA
content/07.Methods.md:10:SDS
content/07.Methods.md:10:supernatant
content/07.Methods.md:10:tris
content/07.Methods.md:12:fastq
content/07.Methods.md:12:FastQC
content/07.Methods.md:12:FeatureCounts
content/07.Methods.md:12:Galazy
content/07.Methods.md:12:Illumina
content/07.Methods.md:12:mRNA
content/07.Methods.md:12:MultiQC
content/07.Methods.md:12:Qiagen
content/07.Methods.md:12:TruSeq
content/07.Methods.md:12:UDI
content/07.Methods.md:14:ARF
content/07.Methods.md:14:Immunofluoresence
content/07.Methods.md:14:Immunohistochemistry
content/07.Methods.md:14:Immunohistochemistry
content/07.Methods.md:14:phospho
content/07.Methods.md:14:SPC
content/07.Methods.md:17:Caseviewer
content/07.Methods.md:17:eosin
content/07.Methods.md:17:Hematoxylin
content/07.Methods.md:17:Histech
content/07.Methods.md:17:Histech
content/07.Methods.md:17:Histech
content/07.Methods.md:17:IHC
content/07.Methods.md:17:Pannoramic
content/07.Methods.md:17:QuantCenter
content/07.Methods.md:17:QuantCenter
content/07.Methods.md:17:Thermo
content/07.Methods.md:19:BD
content/07.Methods.md:19:Cre
content/07.Methods.md:19:cytometer
content/07.Methods.md:19:dabrafenib
content/07.Methods.md:19:HCI
content/07.Methods.md:19:previusly
content/07.Methods.md:19:Spc
content/07.Methods.md:19:trametenib
content/07.Methods.md:23:Actin
content/07.Methods.md:23:wb
content/07.Methods.md:24:IHC
content/07.Methods.md:24:Phospho
content/07.Methods.md:24:wb
content/07.Methods.md:25:wb
content/07.Methods.md:26:IHC
content/07.Methods.md:26:Leica
content/07.Methods.md:26:wb
content/07.Methods.md:27:Abcam
content/07.Methods.md:27:IHC
content/07.Methods.md:28:IHC
content/07.Methods.md:28:Millipore
content/07.Methods.md:28:SPC
content/07.Methods.md:29:IHC
content/07.Methods.md:30:ARF
content/07.Methods.md:30:Sherr
content/07.Methods.md:31:ATCC
content/07.Methods.md:31:CRL
content/07.Methods.md:32:Bivona
content/07.Methods.md:32:HCC
content/07.Methods.md:33:Addgene
content/07.Methods.md:33:Recombinant
content/07.Methods.md:34:Addgene
content/07.Methods.md:34:Recombinant
content/07.Methods.md:35:Addgene
content/07.Methods.md:35:Recombinant
content/07.Methods.md:36:dabrafenib
content/07.Methods.md:36:Selleck
content/07.Methods.md:37:Plexxikon
content/07.Methods.md:38:Selleck
content/07.Methods.md:38:trametinib
content/07.Methods.md:39:Collagenase
content/07.Methods.md:39:Thermo
content/07.Methods.md:40:Dispase
content/07.Methods.md:41:Biochem
content/07.Methods.md:41:Elastase
content/07.Methods.md:41:Worthington
content/07.Methods.md:42:Cre
content/07.Methods.md:42:VVC
